Identification of HLA-E Binding Mycobacterium tuberculosis–Derived Epitopes through Improved Prediction Models

P Ruibal, KLMC Franken… - The Journal of …, 2022 - journals.aai.org
Tuberculosis (TB) remains one of the deadliest infectious diseases worldwide, posing great
social and economic burden to affected countries. Novel vaccine approaches are needed to …

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q

P Niewold, DJ Dijkstra, Y Cai, D Goletti, F Palmieri… - Scientific Reports, 2023 - nature.com
Tuberculosis (TB) is a prevalent disease causing an estimated 1.6 million deaths and 10.6
million new cases annually. Discriminating TB disease from differential diagnoses can be …

[HTML][HTML] Simultaneous detection and differentiation of Mycobacterium tuberculosis and nontuberculous mycobacteria coexisting in patients with pulmonary …

L Heidari, GR Dehbidi, A Farhadi… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Materials and Methods: 100 sputum samples positive for acid-fast bacilli (AFB) were
included in this study. Mycobacterial culture, biochemical tests, and antibiotic susceptibility …

[HTML][HTML] Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease

F Repele, T Alonzi, A Navarra, C Farroni… - International Journal of …, 2024 - Elsevier
Abstract Objectives To investigate whether Mycobacterium tuberculosis (Mtb) DNA is
detected in peripheral blood mononuclear cells (PBMC) of subjects with tuberculosis (TB) or …

Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up

KY Lin, CJ Yang, HY Sun, YT Lee, BH Liou, IM Hii… - Scientific reports, 2022 - nature.com
Testing and treatment of tuberculosis infection (TBI) are recommended for people living with
HIV (PLWH). We aimed to evaluate the care cascade of TBI treatment among PLWH in the …

C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay

G Russomando, D Sanabria, CC Díaz Acosta… - Frontiers in …, 2024 - frontiersin.org
Introduction New diagnostic tools are needed to rapidly assess the efficacy of pulmonary
tuberculosis (PTB) treatment. The aim of this study was to evaluate several immune …

Combined analysis of host IFN-γ, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6/CFP-10 stimulated blood

AM Rapulana, T Mpotje, OO Baiyegunhi… - Frontiers in Molecular …, 2024 - frontiersin.org
Background: Accurate diagnosis of latent tuberculosis infected (LTBI) individuals is
important in identifying individuals at risk of developing active tuberculosis. Current …

Tetrad metal ion mediated molecular switch aptamer sensor for fluorescence assay of plasma IP-10 in clinical tuberculosis

T Shi, P Jiang, Y Wang, Y Xie, B Ying… - Sensors and Actuators B …, 2024 - Elsevier
Abstract Interferon-γ-inducible protein 10 (IP-10) has demonstrated enormous potential as a
novel biomarker for tuberculosis (TB), particularly in the monitoring of patient progression for …

[HTML][HTML] circRNA_SLC8A1 promotes the survival of mycobacterium tuberculosis in macrophages by upregulating expression of autophagy-related protein SQSTM1 …

Z Li, Y Gao, B Zhang, W Dong, Y Xi, Y Li, J Cui - Scientific Reports, 2024 - nature.com
Macrophages act as the first immune defense line of the host against Mycobacterium
tuberculosis (Mtb). A previous study showed that circRNA_SLC8A1 was significantly …

Commercially available CD4+ and CD8+ IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and …

D Buonsenso, G Delogu… - European Journal of …, 2023 - Springer
Commercially available Interferon-γ release assays (IGRAs), including the last-generation
QuantiFERON TB-Plus (QFT-Plus), are effective in aiding the diagnosis of tuberculosis (TB) …